Clinical efficacy of gabapentin for paroxysmal symptoms in multiple sclerosis.
Yetimalar
Y
Y
Gürgör
N
N
Başoğlu
M
M
D000085:Acetates / Q000008:administration & dosage*; D000328:Adult; D000588:Amines; D000927:Anticonvulsants / Q000008:administration & dosage*; D003509:Cyclohexanecarboxylic Acids; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin